Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VLRX - Valeritas Holdings Inc.

Previous close
0.2568
0   0%

Share volume: 0
Last Updated: Wed 19 Feb 2020 06:00:00 AM CET
Medical Specialties: 0%

PREVIOUS CLOSE
CHG
CHG%
$0.26
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
26%
Profitability 25%
Dept financing 25%
Liquidity 72%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.26
P/E Ratio 
N/A
DAY RANGE
$0.26 - $0.26
EPS 
-$11.66
52 WEEK RANGE
$0.25 - $11.39
52 WEEK CHANGE
-$96.75
MARKET CAP 
2.140 M
YIELD 
N/A
SHARES OUTSTANDING 
8.332 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$7,300,893
AVERAGE 10 VOLUME 
$1,553,082
AVERAGE 30 VOLUME 
$722,137
Company detail
CEO: John E. Timberlake
Region: US
Website: http://www.valeritas.com
Employees: 125
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Medical Specialties
Sector: Health Technology

Valeritas Holdings, Inc. is a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with diabetes. It offers products under the V-Go brand. V-Go Disposable Insulin Delivery Device, is used by patients with type 2 diabetes to maintain target blood glucose goals. The firm's single-use disposable V-Go device includes V-Go PreFill and V-Go Link. The company was founded by Leisa Swanson and Robert R. Gonnelli on May 9, 2014 and is headquartered in Bridgewater, NJ.

Recent news